222 related articles for article (PubMed ID: 15703263)
1. A novel class of cytochrome P450 reductase redox cyclers: cationic manganoporphyrins.
Day BJ; Kariya C
Toxicol Sci; 2005 May; 85(1):713-9. PubMed ID: 15703263
[TBL] [Abstract][Full Text] [Related]
2. Flavin-dependent antioxidant properties of a new series of meso-N,N'-dialkyl-imidazolium substituted manganese(III) porphyrins.
Kachadourian R; Johnson CA; Min E; Spasojevic I; Day BJ
Biochem Pharmacol; 2004 Jan; 67(1):77-85. PubMed ID: 14667930
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antioxidant properties of manganese(III) beta-octabromo-meso-tetrakis(4-carboxyphenyl)porphyrin.
Kachadourian R; Flaherty MM; Crumbliss AL; Patel M; Day BJ
J Inorg Biochem; 2003 Jul; 95(4):240-8. PubMed ID: 12818794
[TBL] [Abstract][Full Text] [Related]
4. Cyclic conversion of the novel Src kinase inhibitor [7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-oxide metabolite by flavin-containing monoxygenases and cytochrome P450 reductase.
Kousba A; Soll R; Yee S; Martin M
Drug Metab Dispos; 2007 Dec; 35(12):2242-51. PubMed ID: 17881660
[TBL] [Abstract][Full Text] [Related]
5. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
6. Involvement of a cytochrome P450 system in microsomal debromination of alpha-(bromisovaleryl)urea.
Oka K; Kitamura S; Tatsumi K
J Pharm Pharmacol; 1996 Sep; 48(9):930-2. PubMed ID: 8910855
[TBL] [Abstract][Full Text] [Related]
7. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
Weber GF; Waxman DJ
Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024
[TBL] [Abstract][Full Text] [Related]
8. Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes.
Mikalsen A; Alexander J; Wallin H; Ingelman-Sundberg M; Andersen RA
Carcinogenesis; 1991 May; 12(5):825-31. PubMed ID: 1903091
[TBL] [Abstract][Full Text] [Related]
9. One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase.
Vromans RM; van de Straat R; Groeneveld M; Vermeulen NP
Xenobiotica; 1990 Sep; 20(9):967-78. PubMed ID: 2122607
[TBL] [Abstract][Full Text] [Related]
10. A study on the antioxidant capacities of some benzimidazoles in rat tissues.
Can-Eke B; Puskullu MO; Buyukbingol E; Iscan M
Chem Biol Interact; 1998 May; 113(1):65-77. PubMed ID: 9630848
[TBL] [Abstract][Full Text] [Related]
11. Inhibition studies on the involvement of flavoprotein reductases in menadione- and nitrofurantoin-stimulated oxyradical production by hepatic microsomes of flounder (Platichthys flesus).
Lemaire P; Livingstone DR
J Biochem Toxicol; 1994 Apr; 9(2):87-95. PubMed ID: 8071949
[TBL] [Abstract][Full Text] [Related]
12. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of enzymes of drug metabolism in rat liver by ultrasound and correction by heparin.
Legonkova LF; Bushma MI; Zverinsky IV; Eismont KA
Exp Toxicol Pathol; 1999 Jul; 51(4-5):360-2. PubMed ID: 10445398
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of two classes of azo dye reductase activity associated with rat liver microsomal cytochrome P450.
Zbaida S; Levine WG
Biochem Pharmacol; 1990 Dec; 40(11):2415-23. PubMed ID: 2125221
[TBL] [Abstract][Full Text] [Related]
15. Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N'-diacetylbenzidine.
Lakshmi VM; Zenser TV; Davis BB
Drug Metab Dispos; 1997 Apr; 25(4):481-8. PubMed ID: 9107548
[TBL] [Abstract][Full Text] [Related]
16. Reductase-mediated metabolism of motexafin gadolinium (Xcytrin) in rat and human liver subcellular fractions and purified enzyme preparations.
Mani C; Upadhyay S; Lacy S; Boswell GW; Miles DR
J Pharm Sci; 2005 Mar; 94(3):559-70. PubMed ID: 15666291
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
Chun YJ; Kim MY; Guengerich FP
Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
[TBL] [Abstract][Full Text] [Related]
18. Triphenyltin acetate-mediated in vitro inactivation of rat liver cytochrome P-450.
Nebbia C; Ceppa L; Dacasto M; Carletti M
J Toxicol Environ Health A; 1999 Mar; 56(6):433-47. PubMed ID: 10096365
[TBL] [Abstract][Full Text] [Related]
19. Evidence for requirement of NADPH-cytochrome P450 oxidoreductase in the microsomal NADPH-sterol Delta7-reductase system.
Nishino H; Ishibashi T
Arch Biochem Biophys; 2000 Feb; 374(2):293-8. PubMed ID: 10666310
[TBL] [Abstract][Full Text] [Related]
20. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
